Robbins Wendye's Form 4 filing
RAPT Therapeutics, Inc. (RAPT) · filed Mar 15, 2023
- Accession no.
- 0001209191-23-019023
- Filed
- Mar 15, 2023
- Trade date
- Mar 14, 2023
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 4 non-derivative transactions and 0 derivative transactions. Open-market purchases total $97.6K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Robbins WendyeCIK 0001791244 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 14, 2023 | Common Stock | PPurchaseAcquired | +1,500 | $18.75 | +$28,125 | 13,900 | Direct | |
| Mar 14, 2023 | Common Stock | PPurchaseAcquired | +400 | $18.48 | +$7,392 | 14,300 | Direct | |
| Mar 14, 2023 | Common Stock | PPurchaseAcquired | +600 | $19.95 | +$11,970 | 14,900 | Direct | |
| Mar 14, 2023 | Common Stock | PPurchaseAcquired | +2,500 | $20.05 | +$50,125 | 6,500 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.